01-11-2004
Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: Anticholinergic drugs and botulinum toxin as additional therapeutic options
Published in: Journal of Inherited Metabolic Disease | Issue 6/2004
Login to get access